シンバイオ製薬【4582】 資本金及び資本剰余金の推移

(単位:百万円) 資本金及び資本剰余金 前年比(%)
3Q25 37,664 +2.8%
2Q25 37,171 +1.5%
1Q25 37,151 +2.0%
4Q24 36,649 +2.1%
3Q24 36,640 +4.2%
2Q24 36,633 +4.2%
1Q24 36,420 +3.7%
4Q23 35,880 +2.3%
3Q23 35,176 +0.4%
2Q23 35,170 +0.4%
1Q23 35,113 +2.3%
4Q22 35,072 +2.3%
3Q22 35,048 +2.2%
2Q22 35,036 +2.2%
1Q22 34,313 +0.6%
4Q21 34,290 +0.7%
3Q21 34,280 +3.8%
2Q21 34,268 +3.8%
1Q21 34,115 +10.7%
4Q20 34,064 +14.6%
3Q20 33,028 +16.0%
2Q20 33,013 +16.0%
1Q20 30,807 +18.0%
4Q19 29,714 +14.7%
3Q19 28,460 +14.9%
2Q19 28,459 +23.4%
1Q19 26,112 +17.0%
4Q18 25,915 +20.6%
3Q18 24,773 +19.4%
2Q18 23,062 +13.1%
1Q18 22,320 +9.5%
4Q17 21,493 +8.2%
3Q17 20,755 +5.7%
2Q17 20,385 +8.8%
1Q17 20,381 +22.5%
4Q16 19,867 +19.5%
3Q16 19,642 +18.1%
2Q16 18,742 -
1Q16 16,632 -
4Q15 16,632 0.0%
3Q15 16,632 -
4Q14 16,632 -